Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000551475 | SCV000651001 | benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-21 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001692180 | SCV001911017 | benign | not provided | 2018-09-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002350338 | SCV002620373 | benign | Cardiovascular phenotype | 2020-03-04 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV001692180 | SCV002821852 | benign | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | FLNC: PP3, BS1, BS2 |
Genome Diagnostics Laboratory, |
RCV001703202 | SCV001929682 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001703202 | SCV001969601 | benign | not specified | no assertion criteria provided | clinical testing |